Integra LifeSciences (IART) Competitors

Alphatec (NASDAQ:ATEC) and Integra LifeSciences (NASDAQ:IART) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, media sentiment, community ranking, risk, profitability, valuation and earnings.

Does the media refer more to ATEC or IART?

In the previous week, Alphatec had 2 more articles in the media than Integra LifeSciences. MarketBeat recorded 11 mentions for Alphatec and 9 mentions for Integra LifeSciences. Alphatec's average media sentiment score of 0.80 beat Integra LifeSciences' score of 0.67 indicating that Alphatec is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alphatec	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Integra LifeSciences	3 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Which has more risk & volatility, ATEC or IART?

Alphatec has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500.

Which has higher earnings and valuation, ATEC or IART?

Integra LifeSciences has higher revenue and earnings than Alphatec. Integra LifeSciences is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alphatec	$642.27M	2.77	-$186.64M	-$1.15	-10.57
Integra LifeSciences	$1.62B	0.66	$67.74M	-$0.38	-36.39

Is ATEC or IART more profitable?

Integra LifeSciences has a net margin of -0.42% compared to Alphatec's net margin of -31.06%. Integra LifeSciences' return on equity of 12.35% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alphatec	-31.06%	-541.39%	-22.99%
Integra LifeSciences	-0.42%	12.35%	4.82%

Do insiders and institutionals hold more shares of ATEC or IART?

66.3% of Alphatec shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 20.9% of Alphatec shares are held by insiders. Comparatively, 3.5% of Integra LifeSciences shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Does the MarketBeat Community favor ATEC or IART?

Integra LifeSciences received 102 more outperform votes than Alphatec when rated by MarketBeat users. However, 58.20% of users gave Alphatec an outperform vote while only 56.72% of users gave Integra LifeSciences an outperform vote.

Company	Underperform	Outperform
Alphatec	Outperform Votes 337 58.20%	Underperform Votes 242 41.80%
Integra LifeSciences	Outperform Votes 439 56.72%	Underperform Votes 335 43.28%

Do analysts rate ATEC or IART?

Alphatec presently has a consensus target price of $17.89, indicating a potential upside of 47.11%. Integra LifeSciences has a consensus target price of $18.63, indicating a potential upside of 34.67%. Given Alphatec's stronger consensus rating and higher possible upside, research analysts plainly believe Alphatec is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alphatec	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89
Integra LifeSciences	4 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.78

Summary

Alphatec and Integra LifeSciences tied by winning 9 of the 18 factors compared between the two stocks.